Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

[1]  David Eidelberg,et al.  Imaging markers of mild cognitive impairment: Multivariate analysis of CBF SPECT , 2007, Neurobiology of Aging.

[2]  B. Borroni,et al.  The effect of APOE genotype on clinical phenotype in Alzheimer disease , 2007, Neurology.

[3]  C. Jack,et al.  Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. , 2007, Archives of neurology.

[4]  M. Viitanen,et al.  Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease , 2006, Neurology.

[5]  MRI evidence of bilateral hippocampal sclerosis in amnestic mild cognitive impairment , 2006, European journal of neurology.

[6]  Nick C Fox,et al.  The effect of APOE genotype on clinical phenotype in Alzheimer disease , 2006, Neurology.

[7]  J Philip Miller,et al.  Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI , 2006, Neurology.

[8]  Gina N. LaRossa,et al.  [11C]PIB in a nondemented population , 2006, Neurology.

[9]  D. Bennett,et al.  Alzheimer’s Association Research Roundtable Meeting on Mild Cognitive Impairment: What have we learned? , 2006, Alzheimer's & Dementia.

[10]  Jennifer Farmer,et al.  Frontotemporal dementia: Clinicopathological correlations , 2006, Annals of neurology.

[11]  E. Tangalos,et al.  Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. , 2006, Archives of neurology.

[12]  A. Toga,et al.  Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. , 2006, Archives of neurology.

[13]  Gina N. LaRossa,et al.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.

[14]  K. Blennow,et al.  Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.

[15]  Lucilla Parnetti,et al.  Diagnosing prodromal Alzheimer's disease: Role of CSF biochemical markers , 2006, Mechanisms of Ageing and Development.

[16]  P. Whitehouse,et al.  Mild cognitive impairment , 2006, Lancet.

[17]  D. Anchisi,et al.  Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD , 2006, Neurobiology of Aging.

[18]  W. M. van der Flier,et al.  Hippocampal atrophy in Alzheimer disease: Age matters , 2006, Neurology.

[19]  John C Morris,et al.  Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. , 2006, Archives of neurology.

[20]  B. Winblad,et al.  Clinical trials in mild cognitive impairment: lessons for the future , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  R. Coleman,et al.  Positron emission tomography diagnosis of Alzheimer's disease. , 2005, Neuroimaging clinics of North America.

[22]  Magda Tsolaki,et al.  Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium , 2005, European Psychiatry.

[23]  Faiza Admiraal-Behloul,et al.  MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic , 2005, International journal of geriatric psychiatry.

[24]  D. Perani,et al.  Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. , 2005, Archives of neurology.

[25]  J. Kaye,et al.  Safety and Acceptability of the Research Lumbar Puncture , 2005, Alzheimer disease and associated disorders.

[26]  P. Visser,et al.  Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  Lars Bäckman,et al.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. , 2005, Neuropsychology.

[28]  N. Greig,et al.  Editorial: advances in Alzheimer therapy: something old, something new, something borrowed, something blue. , 2005, Current Alzheimer research.

[29]  Alex Kiss,et al.  Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years , 2005, Neurology.

[30]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[31]  S. DeKosky,et al.  Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  L. Thal,et al.  A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment , 2005, Neuropsychopharmacology.

[33]  S. Gilman,et al.  11C-DTBZ and 18F-FDG PET measures in differentiating dementias. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  Michael I. Miller,et al.  Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly , 2005, NeuroImage.

[35]  K. Blennow,et al.  CSF biomarkers for mild cognitive impairment and early Alzheimer's disease , 2005, Clinical Neurology and Neurosurgery.

[36]  P. Scheltens,et al.  Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients , 2005, Dementia and Geriatric Cognitive Disorders.

[37]  Eric Salmon,et al.  Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer’s disease , 2005, Journal of Neurology.

[38]  D. Perani,et al.  MCI conversion to dementia and the APOE genotype , 2004, Neurology.

[39]  Klaus P. Ebmeier,et al.  Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[40]  Benoit Mulsant,et al.  Detection and Management of Cognitive Impairment in Primary Care: The Steel Valley Seniors Survey , 2004, Journal of the American Geriatrics Society.

[41]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[42]  E. Tangalos,et al.  Mild cognitive impairment: a cross-national comparison , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[43]  M N Rossor,et al.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry , 2004, Neuropathology and applied neurobiology.

[44]  Philip Scheltens,et al.  Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment , 2004, Neurology.

[45]  Dag Aarsland,et al.  Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. , 2004, Archives of neurology.

[46]  P. Scheltens,et al.  Behavioral symptoms in mild cognitive impairment , 2004, Neurology.

[47]  G. Samsa,et al.  Alzheimer disease: operating characteristics of PET--a meta-analysis. , 2004, Radiology.

[48]  M. Albert,et al.  Amnestic MCI or prodromal Alzheimer's disease? , 2004, The Lancet Neurology.

[49]  H. Kung,et al.  Characterization of IMPY as a potential imaging agent for β-amyloid plaques in double transgenic PSAPP mice , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[51]  P. Fossati,et al.  Verbal memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression. , 2004, Journal of psychiatric research.

[52]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[53]  K. Blennow,et al.  CSF markers for incipient Alzheimer's disease , 2003, The Lancet Neurology.

[54]  A. Drzezga,et al.  Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[55]  M. Mesulam,et al.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.

[56]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[57]  Katharina Buerger,et al.  Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. , 2002, Archives of neurology.

[58]  Z Walker,et al.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.

[59]  W. Markesbery,et al.  Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study , 2002, Neurology.

[60]  Frederik Barkhof,et al.  Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion , 2002, The Lancet Neurology.

[61]  P. Scheltens,et al.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.

[62]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[63]  I. Grundke‐Iqbal,et al.  Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients , 2002, Neuroscience Letters.

[64]  Masatoshi Itoh,et al.  Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease. , 2002, The American journal of psychiatry.

[65]  C. Bottino,et al.  Volumetric MRI Measurements Can Differentiate Alzheimer's Disease, Mild Cognitive Impairment, and Normal Aging , 2002, International Psychogeriatrics.

[66]  Sanjiv S Gambhir,et al.  Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[67]  K. Jellinger,et al.  Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. , 2002, Neurology.

[68]  G. Small,et al.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[69]  Patrick L. McGeer,et al.  Inflammation, autotoxicity and Alzheimer disease , 2001, Neurobiology of Aging.

[70]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[71]  D. Bennett,et al.  MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. , 2001, Neurobiology of Aging.

[72]  Satoshi Minoshima,et al.  Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.

[73]  R. V. Van Heertum,et al.  SPECT perfusion imaging in the diagnosis of Alzheimer’s disease , 2001, Neurology.

[74]  F. Pasquier,et al.  Memory Impairment Differs in Frontotemporal Dementia and Alzhemier’s Disease. , 2001, Neurocase.

[75]  L. Hakamies,et al.  [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.

[76]  O L Lopez,et al.  Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I , 2000, Neurology.

[77]  G. Ratcliff,et al.  Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented , 2000, Neurology.

[78]  S. Wisniewski,et al.  Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II , 2000, Neurology.

[79]  P Julin,et al.  Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[80]  Nobuyuki Okamura,et al.  Glucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy Bodies , 2000, Experimental Neurology.

[81]  R. Killiany,et al.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.

[82]  K Patterson,et al.  Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. , 2000, Brain : a journal of neurology.

[83]  A. Convit,et al.  Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[84]  R. Lipton,et al.  Memory impairment on free and cued selective reminding predicts dementia , 2000, Neurology.

[85]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[86]  Hiroyuki Arai,et al.  Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease , 1999, Neuroscience Letters.

[87]  Linda Teri,et al.  Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.

[88]  P. Deyn,et al.  Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF , 1999, Neurology.

[89]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[90]  L. Bouter,et al.  Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. , 1999, The American journal of psychiatry.

[91]  A. Delacourte,et al.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.

[92]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[93]  D. Neary,et al.  Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia , 1999, Journal of neurology, neurosurgery, and psychiatry.

[94]  J. Wegiel,et al.  MRI of entorhinal cortex in mild Alzheimer's disease , 1999, The Lancet.

[95]  B. Dubois,et al.  Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. , 1999, Alzheimer disease and associated disorders.

[96]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[97]  Giovanni B. Frisoni,et al.  Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' , 1998 .

[98]  H. Soininen,et al.  MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects , 1998, Neurobiology of Aging.

[99]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[100]  J. Lindeboom,et al.  Subjective memory complaints in the elderly: Depressive symptoms and future dementia , 1997, British Journal of Psychiatry.

[101]  L. Letenneur,et al.  Épidémiologie des troubles de la mémoire. , 1997 .

[102]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[103]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[104]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[105]  L. Wilkins.  To: The amygdala and intractable temporal lobe epilepsy: A quantitative magnetic resonance imaging study , 1997 .

[106]  J. Kaye,et al.  Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia , 1997, Neurology.

[107]  J. Kaye,et al.  Cognitive Markers Preceding Alzheimer's Dementia in the Healthy Oldest Old , 1997, Journal of the American Geriatrics Society.

[108]  Herman Buschke,et al.  Diagnosis of early dementia by the Double Memory Test , 1997, Neurology.

[109]  Yaakov Stern,et al.  Questionable Dementia: Clinical Course and Predictors of Outcome , 1997, Journal of the American Geriatrics Society.

[110]  M. Bobinski,et al.  Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease , 1997, Neurobiology of Aging.

[111]  T. Radebaugh,et al.  The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association , 1997 .

[112]  [Epidemiology of memory disorders]. , 1997, Therapie.

[113]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[114]  W. Snow,et al.  The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. , 1996, Archives of neurology.

[115]  Jeffrey L. Cummings,et al.  The spectrum of behavioral changes in Alzheimer's disease , 1996, Neurology.

[116]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[117]  R. Wolfert,et al.  Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .

[118]  D. Hogan,et al.  Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. , 1995, Archives of neurology.

[119]  S Lehéricy,et al.  Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[120]  D. Galasko,et al.  Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. , 1995, Annals of neurology.

[121]  Fergus I. M. Craik,et al.  Memory Changes in Normal Aging , 1994 .

[122]  K. Herholz,et al.  Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia. , 1994, Electroencephalography and clinical neurophysiology.

[123]  M. Sliwinski,et al.  Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons , 1994, Neurology.

[124]  Y. Agid,et al.  Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases , 1994, Neurology.

[125]  E G Tangalos,et al.  Memory function in very early Alzheimer's disease , 1994, Neurology.

[126]  R. Lévy,et al.  Aging-Associated Cognitive Decline , 1994, International Psychogeriatrics.

[127]  Jan Six,et al.  Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay , 1993 .

[128]  M. Leon,et al.  Hippocampal atrophy in normal aging. An association with recent memory impairment. , 1993, Archives of neurology.

[129]  D. Knopman,et al.  Overview of dementia lacking distinctive histology: pathological designation of a progressive dementia. , 1993, Dementia.

[130]  L. Lapham,et al.  Clinicopathologic Correlates in Alzheimer Disease: Assessment of Clinical and Pathologic Diagnostic Criteria , 1993, Alzheimer disease and associated disorders.

[131]  M. Vandermeeren,et al.  Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. , 1993, Journal of neurochemistry.

[132]  J. Hodges,et al.  Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. , 1992, Brain : a journal of neurology.

[133]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[134]  G. Alexander,et al.  Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease , 1992, Annals of neurology.

[135]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[136]  N Butters,et al.  Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.

[137]  S. Oppenheimer,et al.  Screening for early dementia using memory complaints from patients and relatives. , 1990, Archives of neurology.

[138]  J. Nalbantoglu,et al.  Genetic Factors in Alzheimer's Disease , 1990, Journal of the American Geriatrics Society.

[139]  D. Knopman,et al.  A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. , 1989, Archives of neurology.

[140]  D. Loewenstein,et al.  Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia. , 1989, European neurology.

[141]  J. Harrison,et al.  Posterior cortical atrophy. , 1989, Clinical and experimental neurology.

[142]  Benson Df,et al.  Posterior cortical atrophy. , 1988, Archives of neurology.

[143]  H. Buschke,et al.  Genuine memory deficits in dementia , 1987 .

[144]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[145]  M. Mesulam,et al.  Slowly progressive aphasia without generalized dementia , 1982, Annals of neurology.

[146]  E. Richardson,et al.  Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.